retatrutide cardiovascular ESC 2024: improves lipid and risk profile in Phase II trial Retatrutide heart rate: what the

Research on other GLP-1 agonists like Semaglutide has consistently shown that women report greater reduction in food cravings and portion sizes compared to men at equivalent doses

Temperature monitoring tools If you are serious about maintaining your GLP-1 medication potency, a refrigerator thermometer is a worthwhile investment

[19] [15] Class warnings for GLP-1-based therapies (pancreatitis, gallbladder disease) apply

Retatrutide is a once-weekly subcutaneous GIPR/GLP-1R/GCGR triple receptor agonist

According to 2024 multi-society guidance (including the American Society of Anesthesiologists), most patients can continue GLP-1 receptor agonists before elective procedures

On the flipside, injectable medications are administered once weekly, meaning they could be better for people who may forget to take a once-daily medication